HEADER TRANSFERASE/TRANSFERASE INHIBITOR 22-MAY-14 4QGG TITLE TMK IN COMPLEX WITH COMPOUND 46, 2-(3-CHLOROPHENOXY)-3-FLUORO-4-{(1R)- TITLE 2 3-METHYL-1-[(3S)-3-(5-METHYL-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)- TITLE 3 YL)PIPERIDIN-1-YL]BUTYL}BENZOIC ACID COMPND MOL_ID: 1; COMPND 2 MOLECULE: THYMIDYLATE KINASE; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: TMK; COMPND 5 SYNONYM: DTMP KINASE; COMPND 6 EC: 2.7.4.9; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: STAPHYLOCOCCUS AUREUS SUBSP. AUREUS; SOURCE 3 ORGANISM_TAXID: 282458; SOURCE 4 STRAIN: MRSA252; SOURCE 5 GENE: SAR0483, TMK; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28A KEYWDS THYMIDINE MONPHOSPHATE, SOLUBLE, TRANSFERASE-TRANSFERASE INHIBITOR KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR N.B.OLIVIER REVDAT 2 02-JUL-14 4QGG 1 JRNL REVDAT 1 11-JUN-14 4QGG 0 JRNL AUTH S.P.KAWATKAR,T.A.KEATING,N.B.OLIVIER,J.N.BREEN,O.M.GREEN, JRNL AUTH 2 S.Y.GULER,M.F.HENTEMANN,J.T.LOCH,A.R.MCKENZIE,J.V.NEWMAN, JRNL AUTH 3 L.G.OTTERSON,G.MARTINEZ-BOTELLA JRNL TITL ANTIBACTERIAL INHIBITORS OF GRAM-POSITIVE THYMIDYLATE JRNL TITL 2 KINASE: STRUCTURE-ACTIVITY RELATIONSHIPS AND CHIRAL JRNL TITL 3 PREFERENCE OF A NEW HYDROPHOBIC BINDING REGION. JRNL REF J.MED.CHEM. V. 57 4584 2014 JRNL REFN ISSN 0022-2623 JRNL PMID 24828090 JRNL DOI 10.1021/JM500463C REMARK 2 REMARK 2 RESOLUTION. 1.62 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.5 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.62 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.67 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.9 REMARK 3 NUMBER OF REFLECTIONS : 49834 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.209 REMARK 3 R VALUE (WORKING SET) : 0.208 REMARK 3 FREE R VALUE : 0.222 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.070 REMARK 3 FREE R VALUE TEST SET COUNT : 2527 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.62 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.66 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.92 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 3560 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.3109 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3386 REMARK 3 BIN R VALUE (WORKING SET) : 0.3093 REMARK 3 BIN FREE R VALUE : 0.3425 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.89 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 174 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3009 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 76 REMARK 3 SOLVENT ATOMS : 172 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 25.32 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 35.56 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -10.35760 REMARK 3 B22 (A**2) : 11.20570 REMARK 3 B33 (A**2) : -0.84820 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -16.76380 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.330 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.101 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.903 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.892 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 3137 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 4254 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1086 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 82 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 471 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 3137 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 417 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3851 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.06 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.14 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 17.70 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4QGG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 23-MAY-14. REMARK 100 THE RCSB ID CODE IS RCSB086023. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-AUG-10 REMARK 200 TEMPERATURE (KELVIN) : 140 REMARK 200 PH : 7-8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : NULL REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : MIRROR REMARK 200 OPTICS : PIXEL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL ARRAY DETECTOR REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : PROCESS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 49913 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.621 REMARK 200 RESOLUTION RANGE LOW (A) : 91.042 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.4 REMARK 200 DATA REDUNDANCY : 3.400 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.03300 REMARK 200 FOR THE DATA SET : 15.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.62 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.71 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.2 REMARK 200 DATA REDUNDANCY IN SHELL : 3.40 REMARK 200 R MERGE FOR SHELL (I) : 0.48300 REMARK 200 R SYM FOR SHELL (I) : 0.48300 REMARK 200 FOR SHELL : 1.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.42 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.17 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: TO OBTAIN THE INHIBITOR BOUND CRYSTAL REMARK 280 FORM OF TMK-S.AUREUS CRYSTALS WERE INITIALLY GROWN IN THE ABSENCE REMARK 280 OF COMPOUND USING THE SITTING DROP METHOD AT 293 K WITH A REMARK 280 RESERVOIR SOLUTION OF 100 MM PCPT (PROPIONATE-CACODYLATE-BISTRIS REMARK 280 PROPANE BUFFER) PH 7-8, 21-24% PEG 3350, 200 MM MG2CL USING 1:1 REMARK 280 PROTEIN:RESERVOIR SOLUTION WITH THE PROTEIN SOLUTION AT 13 MG/ML. REMARK 280 CRYSTALS WERE HARVESTED AND SOAKED OVERNIGHT IN A SOLUTION REMARK 280 CONTAINING 100 MM PCPT, 35% PEG 3350, 200 MM MG2CL AND 1-2 MM OR REMARK 280 COMPOUND FROM A 100 MM DMSO STOCK. AFTER SOAKING THE CRYSTALS REMARK 280 WERE CRYOPROTECTED BY SOAKING FOR 15 MINUTES IN COMPOUND-SOAK REMARK 280 SOLUTION SUPPLEMENTED WITH 20% ETHYLENE GLYCOL., VAPOR DIFFUSION, REMARK 280 SITTING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 45.52100 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: BIOLOGICAL UNIT IS A DIMER. FOR MOLECULE A THE PARTERN IS REMARK 300 X, Y, Z-1. FOR MOLECULE B THE PARTNER IS X, Y, Z+1. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1970 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 17040 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -19.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ILE A 142 REMARK 465 ILE A 143 REMARK 465 LYS A 144 REMARK 465 ASN A 145 REMARK 465 SER A 146 REMARK 465 ARG A 147 REMARK 465 ASP A 148 REMARK 465 GLN A 149 REMARK 465 ASN A 150 REMARK 465 ARG A 151 REMARK 465 LEU A 152 REMARK 465 MET B 1 REMARK 465 LYS B 144 REMARK 465 ASN B 145 REMARK 465 SER B 146 REMARK 465 ARG B 147 REMARK 465 ASP B 148 REMARK 465 GLN B 149 REMARK 465 ASN B 150 REMARK 465 ARG B 151 REMARK 465 LEU B 152 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 11 CG CD OE1 OE2 REMARK 470 GLU A 53 CG CD OE1 OE2 REMARK 470 ASN A 55 CG OD1 ND2 REMARK 470 ASP A 56 CG OD1 OD2 REMARK 470 GLU A 155 CG CD OE1 OE2 REMARK 470 LEU A 157 CG CD1 CD2 REMARK 470 HIS A 172 CG ND1 CD2 CE1 NE2 REMARK 470 ASN A 173 CG OD1 ND2 REMARK 470 GLU A 174 CD OE1 OE2 REMARK 470 SER A 175 OG REMARK 470 GLN A 176 CG CD OE1 NE2 REMARK 470 GLU A 188 CG CD OE1 OE2 REMARK 470 LYS A 200 CG CD CE NZ REMARK 470 LYS A 204 CG CD CE NZ REMARK 470 ILE A 205 CG1 CG2 CD1 REMARK 470 HIS B 24 CG ND1 CD2 CE1 NE2 REMARK 470 ARG B 25 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 49 CG CD CE NZ REMARK 470 GLU B 53 CG CD OE1 OE2 REMARK 470 ASN B 55 CG OD1 ND2 REMARK 470 ILE B 143 CG1 CG2 CD1 REMARK 470 GLU B 155 CG CD OE1 OE2 REMARK 470 LYS B 158 CD CE NZ REMARK 470 GLN B 176 CG CD OE1 NE2 REMARK 470 GLU B 188 CG CD OE1 OE2 REMARK 470 LYS B 204 CG CD CE NZ REMARK 470 ILE B 205 CG1 CG2 CD1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 77 -54.58 -128.28 REMARK 500 ARG A 92 133.64 77.64 REMARK 500 TYR A 93 -142.31 -147.88 REMARK 500 TYR A 103 -60.47 -92.16 REMARK 500 SER A 175 -19.18 -140.85 REMARK 500 GLN A 176 -71.01 -62.03 REMARK 500 ARG B 92 128.41 81.19 REMARK 500 TYR B 93 -142.07 -144.83 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B 482 DISTANCE = 5.59 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 32C A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 32C B 301 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4QG7 RELATED DB: PDB REMARK 900 RELATED ID: 4QGA RELATED DB: PDB REMARK 900 RELATED ID: 4QGG RELATED DB: PDB REMARK 900 RELATED ID: 4QGH RELATED DB: PDB DBREF 4QGG A 1 205 UNP Q6GJI9 KTHY_STAAR 1 205 DBREF 4QGG B 1 205 UNP Q6GJI9 KTHY_STAAR 1 205 SEQRES 1 A 205 MET SER ALA PHE ILE THR PHE GLU GLY PRO GLU GLY SER SEQRES 2 A 205 GLY LYS THR THR VAL ILE ASN GLU VAL TYR HIS ARG LEU SEQRES 3 A 205 VAL LYS ASP TYR ASP VAL ILE MET THR ARG GLU PRO GLY SEQRES 4 A 205 GLY VAL PRO THR GLY GLU GLU ILE ARG LYS ILE VAL LEU SEQRES 5 A 205 GLU GLY ASN ASP MET ASP ILE ARG THR GLU ALA MET LEU SEQRES 6 A 205 PHE ALA ALA SER ARG ARG GLU HIS LEU VAL LEU LYS VAL SEQRES 7 A 205 ILE PRO ALA LEU LYS GLU GLY LYS VAL VAL LEU CYS ASP SEQRES 8 A 205 ARG TYR ILE ASP SER SER LEU ALA TYR GLN GLY TYR ALA SEQRES 9 A 205 ARG GLY ILE GLY VAL GLU GLU VAL ARG ALA LEU ASN GLU SEQRES 10 A 205 PHE ALA ILE ASN GLY LEU TYR PRO ASP LEU THR ILE TYR SEQRES 11 A 205 LEU ASN VAL SER ALA GLU VAL GLY ARG GLU ARG ILE ILE SEQRES 12 A 205 LYS ASN SER ARG ASP GLN ASN ARG LEU ASP GLN GLU ASP SEQRES 13 A 205 LEU LYS PHE HIS GLU LYS VAL ILE GLU GLY TYR GLN GLU SEQRES 14 A 205 ILE ILE HIS ASN GLU SER GLN ARG PHE LYS SER VAL ASN SEQRES 15 A 205 ALA ASP GLN PRO LEU GLU ASN VAL VAL GLU ASP THR TYR SEQRES 16 A 205 GLN THR ILE ILE LYS TYR LEU GLU LYS ILE SEQRES 1 B 205 MET SER ALA PHE ILE THR PHE GLU GLY PRO GLU GLY SER SEQRES 2 B 205 GLY LYS THR THR VAL ILE ASN GLU VAL TYR HIS ARG LEU SEQRES 3 B 205 VAL LYS ASP TYR ASP VAL ILE MET THR ARG GLU PRO GLY SEQRES 4 B 205 GLY VAL PRO THR GLY GLU GLU ILE ARG LYS ILE VAL LEU SEQRES 5 B 205 GLU GLY ASN ASP MET ASP ILE ARG THR GLU ALA MET LEU SEQRES 6 B 205 PHE ALA ALA SER ARG ARG GLU HIS LEU VAL LEU LYS VAL SEQRES 7 B 205 ILE PRO ALA LEU LYS GLU GLY LYS VAL VAL LEU CYS ASP SEQRES 8 B 205 ARG TYR ILE ASP SER SER LEU ALA TYR GLN GLY TYR ALA SEQRES 9 B 205 ARG GLY ILE GLY VAL GLU GLU VAL ARG ALA LEU ASN GLU SEQRES 10 B 205 PHE ALA ILE ASN GLY LEU TYR PRO ASP LEU THR ILE TYR SEQRES 11 B 205 LEU ASN VAL SER ALA GLU VAL GLY ARG GLU ARG ILE ILE SEQRES 12 B 205 LYS ASN SER ARG ASP GLN ASN ARG LEU ASP GLN GLU ASP SEQRES 13 B 205 LEU LYS PHE HIS GLU LYS VAL ILE GLU GLY TYR GLN GLU SEQRES 14 B 205 ILE ILE HIS ASN GLU SER GLN ARG PHE LYS SER VAL ASN SEQRES 15 B 205 ALA ASP GLN PRO LEU GLU ASN VAL VAL GLU ASP THR TYR SEQRES 16 B 205 GLN THR ILE ILE LYS TYR LEU GLU LYS ILE HET 32C A 301 38 HET 32C B 301 38 HETNAM 32C 2-(3-CHLOROPHENOXY)-3-FLUORO-4-{(1R)-3-METHYL-1-[(3S)- HETNAM 2 32C 3-(5-METHYL-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL) HETNAM 3 32C PIPERIDIN-1-YL]BUTYL}BENZOIC ACID FORMUL 3 32C 2(C28 H31 CL F N3 O5) FORMUL 5 HOH *172(H2 O) HELIX 1 1 GLY A 14 VAL A 27 1 14 HELIX 2 2 VAL A 41 GLU A 53 1 13 HELIX 3 3 ASP A 58 LYS A 77 1 20 HELIX 4 4 LYS A 77 GLU A 84 1 8 HELIX 5 5 TYR A 93 GLN A 101 1 9 HELIX 6 6 GLY A 108 ASN A 121 1 14 HELIX 7 7 SER A 134 ARG A 141 1 8 HELIX 8 8 GLN A 154 HIS A 172 1 19 HELIX 9 9 PRO A 186 LYS A 204 1 19 HELIX 10 10 GLY B 14 VAL B 27 1 14 HELIX 11 11 VAL B 41 GLY B 54 1 14 HELIX 12 12 ASP B 58 LYS B 77 1 20 HELIX 13 13 LYS B 77 GLU B 84 1 8 HELIX 14 14 TYR B 93 GLN B 101 1 9 HELIX 15 15 GLY B 108 ASN B 121 1 14 HELIX 16 16 SER B 134 ILE B 143 1 10 HELIX 17 17 GLN B 154 GLU B 174 1 21 HELIX 18 18 PRO B 186 LYS B 204 1 19 SHEET 1 A 5 VAL A 32 ARG A 36 0 SHEET 2 A 5 VAL A 87 ASP A 91 1 O ASP A 91 N THR A 35 SHEET 3 A 5 ALA A 3 GLU A 8 1 N ILE A 5 O CYS A 90 SHEET 4 A 5 LEU A 127 ASN A 132 1 O LEU A 131 N GLU A 8 SHEET 5 A 5 PHE A 178 ASN A 182 1 O VAL A 181 N TYR A 130 SHEET 1 B 5 VAL B 32 THR B 35 0 SHEET 2 B 5 VAL B 87 ASP B 91 1 O LEU B 89 N THR B 35 SHEET 3 B 5 ALA B 3 GLU B 8 1 N ALA B 3 O VAL B 88 SHEET 4 B 5 LEU B 127 ASN B 132 1 O LEU B 131 N GLU B 8 SHEET 5 B 5 PHE B 178 ASN B 182 1 O VAL B 181 N TYR B 130 CISPEP 1 GLU A 37 PRO A 38 0 -1.59 CISPEP 2 GLU B 37 PRO B 38 0 -7.26 SITE 1 AC1 14 GLU A 37 ARG A 48 LEU A 52 PHE A 66 SITE 2 AC1 14 SER A 69 ARG A 70 ARG A 92 SER A 97 SITE 3 AC1 14 TYR A 100 GLN A 101 HOH A 459 HOH A 462 SITE 4 AC1 14 HIS B 172 SER B 175 SITE 1 AC2 14 GLU B 11 GLU B 37 ARG B 48 PHE B 66 SITE 2 AC2 14 SER B 69 ARG B 70 ARG B 92 SER B 97 SITE 3 AC2 14 TYR B 100 GLN B 101 HOH B 423 HOH B 461 SITE 4 AC2 14 HOH B 474 HOH B 490 CRYST1 46.996 91.042 48.504 90.00 100.63 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021278 0.000000 0.003994 0.00000 SCALE2 0.000000 0.010984 0.000000 0.00000 SCALE3 0.000000 0.000000 0.020977 0.00000 MASTER 335 0 2 18 10 0 8 6 0 0 0 32 END